Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

IN BRIEF: RTW Venture Fund's Tarsus Prices US IPO At USD88 Million

19th Oct 2020 21:20

RTW Venture Fund Ltd - New York-based investment company which invests in life sciences, biopharmaceutical, and medical technology companies - Portfolio firm Tarsus Pharmaceuticals Inc prices USD88 million initial public offering on Nasdaq Global Market. Company issued 5.5 million shares at USD16.00 per share.

Tarsus is a bioopharmaceutical firm focused on the development of first-in class therapeutics for ophthalmic conditions for which there are limited treatment alternatives. On first day of trading, shares rose by 29% in value to USD20.58.

Current stock price: USD1.54

Year-to-date change: up 12%

By Dayo Laniyan; dayolaniyan@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.


Related Shares:

Rtw Biotech
FTSE 100 Latest
Value9,120.31
Change-18.06